We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Viva Biotech

News List

Viva Biotech and SYNthesis Enter Strategic Acquisition Agreement contractpharma
September 22, 2020
Accelerates Viva’s development of global innovative drug R&D service capabilities.
Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities prnasia
September 21, 2020
Viva Biotech (Shanghai) Co., Ltd. entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 100% of the equity interest in SYNthesis med chem (Hong Kong, S.A.R., China) Limited .
Viva Biotech Awarded 'Top 10 Public Companies' prnasia
December 25, 2019
The 'Future Healthcare VB 100 Summit' organized by VCBeat and VCBeat Research was held in Beijing. Viva Biotech was invited to the Summit and awarded the 'Top 10 Public Companies 2019' with honor.